MUSC researchers used machine learning on fMRI scans to predict which smokers would benefit from repetitive transcranial magnetic stimulation (rTMS) for quitting smoking.
Key Details
- 1MUSC study combines machine learning and fMRI to personalize rTMS for smoking cessation.
- 242 participants took part in an earlier study, split into real vs sham TMS groups.
- 3The salience network's connectivity in the brain, analyzed by AI, correlated best with positive rTMS outcomes.
- 4Machine learning enabled predictions of individual responsiveness to rTMS based on brain network analysis.
- 5Study published in Brain Connectivity; NIH grant support cited.
- 6The research establishes groundwork for precision neuromodulation and larger future trials.
Why It Matters
This study demonstrates how imaging AI can enhance precision medicine by analyzing fMRI scans to tailor neuromodulation therapies. The approach could extend to other substance use disorders, highlighting a broader potential impact for radiology-based AI tools.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.